Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study

BACKGROUND: We compared the risk of bleeding and cardiovascular disease (CVD) events between non-vitamin K antagonist oral anticoagulant (NOAC) and warfarin in people with type 2 diabetes (T2DM). METHODS: 862 Incident NOAC users and 626 incident warfarin users with T2DM were identified from within 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dahai, Zhao, Zhanzheng, Simmons, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548035/
https://www.ncbi.nlm.nih.gov/pubmed/33038936
http://dx.doi.org/10.1186/s12933-020-01152-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548035/
https://www.ncbi.nlm.nih.gov/pubmed/33038936
http://dx.doi.org/10.1186/s12933-020-01152-y

Ejemplares similares